Literature DB >> 16225405

Cystic fibrosis newborn screening: a pilot study to maximize carrier screening.

Erin Lagoe1, Sandra Labella, Georgianne Arnold, Peter T Rowley.   

Abstract

Newborn screening for cystic fibrosis (CF) is expanding because early diagnosis has been shown to result in improved nutrition and growth. Most newborns identified by a mutation panel have a single detected mutation and require sweat testing to exclude an additional undetected mutation. The resulting identification of CF carrier newborns, although not the primary purpose of screening, has three potential benefits, (1) the detection of trait-trait couples, (2) presymptomatic testing of these couples' previously born children who may have undetected CF, and (3) a carrier parent alerting his/her extended family members to the chance of also being a CF carrier. Reaping each benefit requires genetic counseling of parents and their accepting carrier testing. The purpose of this study was to utilize the sweat testing visit to educate parents about the value of carrier testing for themselves and their blood relatives. We compared special care (genetic counseling after explaining the sweat test result and offering of parental DNA testing, all on the sweat test visit) versus standard care (sweat test result reported by phone to the parents the next day by the newborn's physician, ideally with the recommendation to arrange genetic counseling and parental carrier testing). In the first year of New York State CF screening, 64 newborns with one detected mutation were reported in the nine-county region that includes Rochester. Of these, parents of 39 agreed to participate in the study and to be randomized to special or standard care. Sixty-one parents completed both the initial and 1-year follow-up questionnaires (30 couples and one mother). Of the 61 parents, 23 had carrier testing after the birth of the baby. The frequency of such parental testing was significantly higher in the special care group (17/34 or 50%) than in the standard care group (6/27 or 22%) (p < 0.05). This is the first evidence from a randomized trial that genetic counseling and offering carrier testing to parents on the sweat test visit increases identification of carrier parents. Such identification detects trait-trait parents and facilitates carrier testing among relatives.

Entities:  

Mesh:

Year:  2005        PMID: 16225405     DOI: 10.1089/gte.2005.9.255

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  7 in total

Review 1.  A systematic review of the effects of disclosing carrier results generated through newborn screening.

Authors:  R Z Hayeems; J P Bytautas; F A Miller
Journal:  J Genet Couns       Date:  2008-10-28       Impact factor: 2.537

2.  Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening.

Authors:  Belinda J McClaren; Sylvia A Metcalfe; Maryanne Aitken; R John Massie; Obioha C Ukoumunne; David J Amor
Journal:  Eur J Hum Genet       Date:  2010-05-26       Impact factor: 4.246

3.  Attitudes of cystic fibrosis patients and parents toward carrier screening and related reproductive issues.

Authors:  Sandra Janssens; Davit Chokoshvilli; Carmen Binst; Inge Mahieu; Lidewij Henneman; Anne De Paepe; Pascal Borry
Journal:  Eur J Hum Genet       Date:  2015-07-29       Impact factor: 4.246

Review 4.  Newborn screening for cystic fibrosis.

Authors:  Kevin W Southern; Marieke M E Mérelle; Jeannette E Dankert-Roelse; A D Nagelkerke
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

5.  A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis.

Authors:  Yvonne Bombard; Fiona A Miller; Carolyn J Barg; Sarah J Patton; June C Carroll; Pranesh Chakraborty; Beth K Potter; Karen Tam; Louise Taylor; Elizabeth Kerr; Christine Davies; Jennifer Milburn; Felix Ratjen; Astrid Guttmann; Robin Z Hayeems
Journal:  Genet Med       Date:  2016-09-08       Impact factor: 8.822

Review 6.  Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders.

Authors:  Samuel M Moskowitz; James F Chmiel; Darci L Sternen; Edith Cheng; Ronald L Gibson; Susan G Marshall; Garry R Cutting
Journal:  Genet Med       Date:  2008-12       Impact factor: 8.822

7.  Informing children of their newborn screening carrier result for sickle cell or cystic fibrosis: qualitative study of parents' intentions, views and support needs.

Authors:  Fiona Ulph; Tim Cullinan; Nadeem Qureshi; Joe Kai
Journal:  J Genet Couns       Date:  2013-12-04       Impact factor: 2.537

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.